Lipoteichoic acid (LTA) and lipopolysaccharides (LPS) from periodontal pathogenic bacteria facilitate oncogenic herpesvirus infection within primary oral cells

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Dai, Lu ^a,b   DeFee, Michael R ^c   Cao, Yueyu ^a   Wen, Jiling ^a   Wen, Xiaofei ^a   Noverr, Mairi C ^d   Qin, Zhiqiang ^a,b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PROTEOHEPARAN SULFATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TEICHOIC ACID; VIRUS PROTEIN;

ARTICLE; BACTERIUM; BACTERIUM CARRIER; ENZYME ACTIVITY; FIBROBLAST; GENE EXPRESSION; HERPES VIRUS INFECTION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; INFECTION RISK; INTRACELLULAR SIGNALING; KAPOSI SARCOMA; MOUTH CAVITY; NONHUMAN; ONCOGENIC HERPESVIRUS INFECTION; PERIODONTAL DISEASE; PERIODONTAL PATHOGENIC BACTERIUM; PORPHYROMONAS GINGIVALIS; PRIMARY CELL; PRIMARY ORAL CELL; STAPHYLOCOCCUS AUREUS; UPREGULATION; VIRUS ENTRY; VIRUS REPLICATION; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; MICROBIOLOGY; MOUTH; PATHOGENICITY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; VIROLOGY;

CELL LINE, TUMOR; CELLS, CULTURED; FIBROBLASTS; HERPESVIRUS 8, HUMAN; HUMANS; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; MOUTH; NF-KAPPA B; PORPHYROMONAS GINGIVALIS; REACTIVE OXYGEN SPECIES; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS; VIRAL PROTEINS; VIRUS INTERNALIZATION;

EID: 84903397341     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101326     Document Type: Article

References (80)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
2. Bonnet F, Lewden C, May T, Heripret L, Jougla E, et al. (2004) Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 101: 317-324. (Pubitemid 38890835)
3. Lebbe C, Legendre C, Frances C (2008) Kaposi sarcoma in transplantation. Transplant Rev (Orlando) 22: 252-261.
4. Seaberg EC, Wiley D, Martinez-Maza O, Chmiel JS, Kingsley L, et al. (2010) Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer 116: 5507-5516.
5. Vanni T, Sprinz E, Machado MW, Santana Rde C, Fonseca BA, et al. (2006) Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives. Cancer Treat Rev 32: 445-455. (Pubitemid 44309251)
6. Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, et al. (2000) Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 343: 1369-1377.
7. Casper C, Redman M, Huang ML, Pauk J, Lampinen TM, et al. (2004) HIV infection and human herpesvirus-8 oral shedding among men who have sex with men. J Acquir Immune Defic Syndr 35: 233-238. (Pubitemid 38280648)
8. Dukers NH, Renwick N, Prins M, Geskus RB, Schulz TF, et al. (2000) Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am J Epidemiol 151: 213-224. (Pubitemid 30463624)
9. Miller CS, Berger JR, Mootoor Y, Avdiushko SA, Zhu H, et al. (2006) High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol 44: 2409-2415. (Pubitemid 44109662)
10. Osmond DH, Buchbinder S, Cheng A, Graves A, Vittinghoff E, et al. (2002) Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic. JAMA 287: 221-225. (Pubitemid 34251948)
11. Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ, Jr. (2000) Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89: 299-304.
12. Ramirez-Amador V, Martinez-Mata G, Gonzalez-Ramirez I, Anaya-Saavedra G, de Almeida OP (2009) Clinical, histological and immunohistochemical findings in oral Kaposi's sarcoma in a series of Mexican AIDS patients. Comparative study. J Oral Pathol Med 38: 328-333.
13. Griffen AL, Beall CJ, Campbell JH, Firestone ND, Kumar PS, et al. (2012) Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J 6: 1176-1185.
14. Phiri R, Feller L, Blignaut E (2010) The severity, extent and recurrence of necrotizing periodontal disease in relation to HIV status and CD4+ T cell count. J Int Acad Periodontol 12: 98-103.
15. Mataftsi M, Skoura L, Sakellari D (2011) HIV infection and periodontal diseases: an overview of the post-HAART era. Oral Dis 17: 13-25.
16. Zambon JJ, Reynolds HS, Genco RJ (1990) Studies of the subgingival microflora in patients with acquired immunodeficiency syndrome. J Periodontol 61: 699-704.
17. Nakou M, Kamma J, Gargalianos P, Laskaris G, Mitsis F (1997) Periodontal microflora of HIV infected patients with periodontitis. Anaerobe 3: 97-102. (Pubitemid 27423132)
18. Cole J, Popovich K (2013) Impact of community-associated methicillin resistant Staphylococcus aureus on HIV-infected patients. Curr HIV/AIDS Rep 10: 244-253.
19. Groome MJ, Albrich WC, Wadula J, Khoosal M, Madhi SA (2012) Community-onset Staphylococcus aureus bacteraemia in hospitalised African children: high incidence in HIV-infected children and high prevalence of multidrug resistance. Paediatr Int Child Health 32: 140-146.
20. Shadyab AH, Crum-Cianflone NF (2012) Methicillin-resistant Staphylococcus aureus (MRSA) infections among HIV-infected persons in the era of highly active antiretroviral therapy: a review of the literature. HIV Med 13: 319-332.
21. Rohrmus B, Thoma-Greber EM, Bogner JR, Rocken M (2000) Outlook in oral and cutaneous Kaposi's sarcoma. Lancet 356: 2160. (Pubitemid 32047959)
22. Gorsky M, Epstein JB (2000) A case series of acquired immunodeficiency syndrome patients with initial neoplastic diagnoses of intraoral Kaposi's sarcoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90: 612-617.
23. Cassai E, Galvan M, Trombelli L, Rotola A (2003) HHV-6, HHV-7, HHV-8 in gingival biopsies from chronic adult periodontitis patients. A case-control study. J Clin Periodontol 30: 184-191. (Pubitemid 38011191)
24. Saygun I, Kubar A, Ozdemir A, Slots J (2005) Periodontitis lesions are a source of salivary cytomegalovirus and Epstein-Barr virus. J Periodontal Res 40: 187-191. (Pubitemid 40417319)
25. Slots J (2010) Human viruses in periodontitis. Periodontol 2000 53: 89-110.
26. Slots J (2011) Herpesvirus periodontitis: infection beyond biofilm. J Calif Dent Assoc 39: 393-399.
27. Kumar H, Kawai T, Akira S (2011) Pathogen recognition by the innate immune system. Int Rev Immunol 30: 16-34.
28. Morath S, von Aulock S, Hartung T (2005) Structure/function relationships of lipoteichoic acids. J Endotoxin Res 11: 348-356. (Pubitemid 41724231)
29. Zeytun A, van Velkinburgh JC, Pardington PE, Cary RR, Gupta G (2007) Pathogen-specific innate immune response. Adv Exp Med Biol 598: 342-357.
30. Siqueira JF Jr, Rocas IN (2007) Bacterial pathogenesis and mediators in apical periodontitis. Braz Dent J 18: 267-280.
31. Jain S, Darveau RP (2010) Contribution of Porphyromonas gingivalis lipopolysaccharide to periodontitis. Periodontol 2000 54: 53-70.
32. Dai L, Qin Z, Defee M, Toole BP, Kirkwood KL, et al. (2012) Kaposi sarcoma-associated herpesvirus (KSHV) induces a functional tumor-associated phenotype for oral fibroblasts. Cancer Lett 318: 214-220.
33. Akula SM, Naranatt PP, Walia NS, Wang FZ, Fegley B, et al. (2003) Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis. J Virol 77: 7978-7990. (Pubitemid 36792794)
34. Offermann MK (1996) Kaposi's sarcoma and HHV-8. Trends Microbiol 4: 419.
35. Birkmann A, Mahr K, Ensser A, Yaguboglu S, Titgemeyer F, et al. (2001) Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1. J Virol 75: 11583-11593. (Pubitemid 33063250)
36. Rappocciolo G, Jenkins FJ, Hensler HR, Piazza P, Jais M, et al. (2006) DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages. J Immunol 176: 1741-1749. (Pubitemid 43134319)
37. Akula SM, Pramod NP, Wang FZ, Chandran B (2002) Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells. Cell 108: 407-419. (Pubitemid 34178404)
38. Garrigues HJ, Rubinchikova YE, Dipersio CM, Rose TM (2008) Integrin alphaVbeta3 Binds to the RGD motif of glycoprotein B of Kaposi's sarcoma-associated herpesvirus and functions as an RGD-dependent entry receptor. J Virol 82: 1570-1580.
39. Kaleeba JA, Berger EA (2006) Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT. Science 311: 1921-1924.
40. Whitelock JM, Iozzo RV (2005) Heparan sulfate: a complex polymer charged with biological activity. Chem Rev 105: 2745-2764. (Pubitemid 41055329)
41. Reddi HV, Kumar AS, Kung AY, Kallio PD, Schlitt BP, et al. (2004) Heparan sulfate-independent infection attenuates high-neurovirulence GDVII virus-induced encephalitis. J Virol 78: 8909-8916. (Pubitemid 39025156)
42. Jones KS, Petrow-Sadowski C, Bertolette DC, Huang Y, Ruscetti FW (2005) Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells. J Virol 79: 12692-12702. (Pubitemid 41433189)
43. Bottero V, Chakraborty S, Chandran B (2013) Reactive Oxygen Species Are Induced by Kaposi's Sarcoma-Associated Herpesvirus Early during Primary Infection of Endothelial Cells To Promote Virus Entry. J Virol 87: 1733-1749.
44. Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313. (Pubitemid 46209993)
45. Lambeth JD (2004) NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189.
46. Lee JM, Kim SS, Cho YS (2012) The Role of PPARgamma in Helicobacter pylori Infection and Gastric Carcinogenesis. PPAR Res 2012: 687570.
47. Ye F, Zhou F, Bedolla RG, Jones T, Lei X, et al. (2011) Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency. PLoS Pathog 7: e1002054.
48. Ma Q, Cavallin LE, Leung HJ, Chiozzini C, Goldschmidt-Clermont PJ, et al. (2013) A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis. Antioxid Redox Signal 18: 80-90.
49. Qin Z, Dai L, Defee M, Findlay VJ, Watson DK, et al. (2013) Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection. J Virol 87: 621-635.
50. Defee MR, Qin Z, Dai L, Toole BP, Isaacs JS, et al. (2011) Extracellular Hsp90 serves as a co-factor for NF-kappaB activation and cellular pathogenesis induced by an oncogenic herpesvirus. Am J Cancer Res 1: 687-700.
51. Sharma-Walia N, Krishnan HH, Naranatt PP, Zeng L, Smith MS, et al. (2005) ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. J Virol 79: 10308-10329. (Pubitemid 41098572)
52. Sadagopan S, Sharma-Walia N, Veettil MV, Raghu H, Sivakumar R, et al. (2007) Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression. J Virol 81: 3949-3968. (Pubitemid 46586891)
53. Flaitz CM, Jin YT, Hicks MJ, Nichols CM, Wang YW, et al. (1997) Kaposi's sarcoma-associated herpesvirus-like DNA sequences (KSHV/HHV-8) in oral AIDS-Kaposi's sarcoma: a PCR and clinicopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83: 259-264. (Pubitemid 127670960)
54. Pak F, Pyakural P, Kokhaei P, Kaaya E, Pourfathollah AA, et al. (2005) HHV-8/KSHV during the development of Kaposi's sarcoma: evaluation by polymerase chain reaction and immunohistochemistry. J Cutan Pathol 32: 21-27. (Pubitemid 40174101)
55. Lager I, Altini M, Coleman H, Ali H (2003) Oral Kaposi's sarcoma: a clinicopathologic study from South Africa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96: 701-710. (Pubitemid 37550077)
56. Rohrmus B, Thoma-Greber EM, Bogner JR, Rocken M (2000) Outlook in oral and cutaneous Kaposi's sarcoma. Lancet 356: 2160. (Pubitemid 32047959)
57. Yu X, Shahir AM, Sha J, Feng Z, Eapen B, et al. (2014) Short-Chain Fatty Acids from Periodontal Pathogens Suppress Histone Deacetylases, EZH2, and SUV39H1 To Promote Kaposi's Sarcoma-Associated Herpesvirus Replication. J Virol 88: 4466-4479.
58. Qin Z, Freitas E, Sullivan R, Mohan S, Bacelieri R, et al. (2010) Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress. PLoS Pathog 6: e1000742.
59. Lester SN, Li K (2014) Toll-Like Receptors in Antiviral Innate Immunity. J Mol Biol 426: 1246-1264.
60. West J, Damania B (2008) Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection. J Virol 82: 5440-5449. (Pubitemid 351705251)
61. Lagos D, Vart RJ, Gratrix F, Westrop SJ, Emuss V, et al. (2008) Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus. Cell host & microbe 4: 470-483.
62. Gregory SM, West JA, Dillon PJ, Hilscher C, Dittmer DP, et al. (2009) Toll-like receptor signaling controls reactivation of KSHV from latency. Proc Natl Acad Sci U S A 106: 11725-11730.
63. Abend JR, Ramalingam D, Kieffer-Kwon P, Uldrick TS, Yarchoan R, et al. (2012) Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression. J Virol 86: 11663-11674.
64. Andrukhov O, Ertlschweiger S, Moritz A, Bantleon HP, Rausch-Fan X (2013) Different effects of P. gingivalis LPS and E. coli LPS on the expression of interleukin-6 in human gingival fibroblasts. Acta Odontol Scand.
65. Nogueira-Filho G, Rosa BT, Santos PF, Tunes UR, Freire SM, et al. (2014) Whole-blood cultures from patients with chronic periodontitis respond differently to Porphyromonas gingivalis but not Escherichia coli lipopolysaccharide. J Periodontol 85: e18-23.
66. Paramonov N, Bailey D, Rangarajan M, Hashim A, Kelly G, et al. (2001) Structural analysis of the polysaccharide from the lipopolysaccharide of Porphyromonas gingivalis strain W50. Eur J Biochem 268: 4698-4707. (Pubitemid 34203418)
67. Paramonov NA, Aduse-Opoku J, Hashim A, Rangarajan M, Curtis MA (2009) Structural analysis of the core region of O-lipopolysaccharide of Porphyromonas gingivalis from mutants defective in O-antigen ligase and O-antigen polymerase. J Bacteriol 191: 5272-5282.
68. Bostanci N, Belibasakis GN (2012) Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen. FEMS Microbiol Lett 333: 1-9.
69. Schlafer S, Riep B, Griffen AL, Petrich A, Hubner J, et al. (2010) Filifactor alocis-involvement in periodontal biofilms. BMC Microbiol 10: 66.
70. Kim H, Jung BJ, Kim JY, Chung DK (2014) Differential effects of low and high doses of lipoteichoic acid on lipopolysaccharide-induced interleukin-6 production. Inflamm Res 63: 419-428.
71. Mutig N, Geers-Knoerr C, Piep B, Pahuja A, Vogt PM, et al. (2013) Lipoteichoic acid from Staphylococcus aureus directly affects cardiomyocyte contractility and calcium transients. Mol Immunol 56: 720-728.
72. Zhang Y, Li X (2014) Lipopolysaccharide-regulated production of bone sialoprotein and interleukin-8 in human periodontal ligament fibroblasts: the role of toll-like receptors 2 and 4 and the MAPK pathway. J Periodontal Res.
73. Doyle CJ, Fitzsimmons TR, Marchant C, Dharmapatni AA, Hirsch R, et al. (2014) Azithromycin suppresses P. gingivalis LPS-induced pro-inflammatory cytokine and chemokine production by human gingival fibroblasts in vitro. Clin Oral Investig.
74. Guo S, Takahashi K, Kokeguchi S, Takashiba S, Kinane DF, et al. (2000) Antibody responses against Porphyromonas gingivalis infection in patients with early-onset periodontitis. J Clin Periodontol 27: 769-777.
75. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, et al. (2010) The human oral microbiome. J Bacteriol 192: 5002-5017.
76. Griffen AL, Beall CJ, Firestone ND, Gross EL, Difranco JM, et al. (2011) CORE: a phylogenetically-curated 16S rDNA database of the core oral microbiome. PLoS One 6: e19051.
77. Beazley VC, Thrane P, Rolla G (1980) Effect of mouthrinses with SnF2, LaCl3, NaF and chlorhexidine on the amount of lipoteichoic acid formed in plaque. Scand J Dent Res 88: 193-200. (Pubitemid 10020485)
78. Lee JK, Baik JE, Yun CH, Lee K, Han SH, et al. (2009) Chlorhexidine gluconate attenuates the ability of lipoteichoic acid from Enterococcus faecalis to stimulate toll-like receptor 2. J Endod 35: 212-215.
79. Adang LA, Parsons CH, Kedes DH (2006) Asynchronous progression through the lytic cascade and variations in intracellular viral loads revealed by high-throughput single-cell analysis of Kaposi's sarcoma-associated herpesvirus infection. J Virol 80: 10073-10082. (Pubitemid 44522601)
80. Ballestas ME, Chatis PA, Kaye KM (1999) Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284: 641-644. (Pubitemid 29289588)